Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome.
作者信息
Gavriatopoulou Maria, Ntanasis-Stathopoulos Ioannis, Fotiou Despina, Migkou Magdalini, Eleutherakis-Papaiakovou Evangelos, Kanellias Nikolaos, Roussou Maria, Dialoupi Ioanna, Malandrakis Panagiotis, Theodorakakou Foteini, Kastritis Efstathios, Terpos Evangelos, Dimopoulos Meletios-Athanasios
机构信息
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Alexandra General Hospital, Athens, Greece.
出版信息
Hemasphere. 2020 May 21;4(3):e381. doi: 10.1097/HS9.0000000000000381. eCollection 2020 Jun.
Abstract
摘要
相似文献
1
Upfront Daratumumab With Lenalidomide and Dexamethasone for POEMS Syndrome.达雷妥尤单抗联合来那度胺和地塞米松一线治疗POEMS综合征
Hemasphere. 2020 May 21;4(3):e381. doi: 10.1097/HS9.0000000000000381. eCollection 2020 Jun.
2
[Treatment of POEMS syndrome with lenalidomide and dexamethasone].来那度胺与地塞米松治疗POEMS综合征
Rinsho Ketsueki. 2019;60(4):308-313. doi: 10.11406/rinketsu.60.308.
3
[Successful treatment of POEMS syndrome-associated pulmonary hypertension with lenalidomide and dexamethasone therapy].[来那度胺与地塞米松联合治疗POEMS综合征相关肺动脉高压取得成功]
Rinsho Ketsueki. 2018;59(5):489-491. doi: 10.11406/rinketsu.59.489.
4
Daratumumab plus lenalidomide and dexamethasone lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.达雷妥尤单抗联合来那度胺和地塞米松 vs. 来那度胺和地塞米松治疗复发或难治性多发性骨髓瘤：POLLUX 更新分析。
Haematologica. 2018 Dec;103(12):2088-2096. doi: 10.3324/haematol.2018.194282. Epub 2018 Sep 20.
5
Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.来那度胺治疗沙利度胺难治性POEMS综合征：一项前瞻性单臂临床试验。
Intern Med. 2020 May 1;59(9):1149-1153. doi: 10.2169/internalmedicine.3800-19. Epub 2020 Feb 1.
6
Improvement of thyroid function in POEMS syndrome after combination therapy of lenalidomide and dexamethasone.来那度胺联合地塞米松治疗后 POEMS 综合征患者甲状腺功能改善。
Leuk Lymphoma. 2019 Feb;60(2):483-487. doi: 10.1080/10428194.2018.1485909. Epub 2018 Nov 8.
7
Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.来那度胺与地塞米松治疗POEMS综合征患者：一项前瞻性、开放标签试验的结果
Br J Haematol. 2017 Dec;179(5):748-755. doi: 10.1111/bjh.14966. Epub 2017 Oct 19.
8
Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.低剂量来那度胺联合地塞米松治疗复发或难治性POEMS综合征患者的疗效与安全性。
Eur J Haematol. 2015 Oct;95(4):325-30. doi: 10.1111/ejh.12492. Epub 2015 Feb 10.
9
[Effective treatment of POEMS syndrome accompanied by plasmacytoma with lenalidomide, dexamethasone, and local irradiation].[来那度胺、地塞米松及局部放疗有效治疗伴有浆细胞瘤的POEMS综合征]
Rinsho Ketsueki. 2020;61(3):262-267. doi: 10.11406/rinketsu.61.262.
10
A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.一项前瞻性 II 期研究，评估低剂量来那度胺联合地塞米松治疗新诊断的多发性神经病、器官肿大、内分泌病、单克隆丙种球蛋白病和皮肤改变（POEMS）综合征患者的疗效。
Am J Hematol. 2018 Jun;93(6):803-809. doi: 10.1002/ajh.25100. Epub 2018 Apr 18.
引用本文的文献
1
[Chinese expert consensus on the diagnosis and treatment of POEMS syndrome (2025)].《POEMS综合征诊断与治疗中国专家共识（2025年版）》
Zhonghua Xue Ye Xue Za Zhi. 2025 May 14;46(5):389-396. doi: 10.3760/cma.j.cn121090-20241219-00578.
2
First-line therapy with daratumumab, lenalidomide and dexamethasone for patient with POEMS syndrome: A case report.达雷妥尤单抗、来那度胺和地塞米松一线治疗POEMS综合征患者：一例报告
Leuk Res Rep. 2024 Nov 26;22:100491. doi: 10.1016/j.lrr.2024.100491. eCollection 2024.
3
Neurological manifestations of MGUS.意义未明的单克隆丙种球蛋白病的神经系统表现。
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):499-504. doi: 10.1182/hematology.2024000665.
4
Daratumumab-based treatment of monoclonal gammopathy-associated angioedema due to acquired C1-inhibitor deficiency.基于达雷妥尤单抗治疗获得性C1抑制物缺乏所致单克隆丙种球蛋白病相关血管性水肿。
J Allergy Clin Immunol Glob. 2024 Aug 5;3(4):100322. doi: 10.1016/j.jacig.2024.100322. eCollection 2024 Nov.
5
Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review.病例报告：DKRd方案治疗新诊断的POEMS综合征及文献综述
Front Oncol. 2024 Aug 1;14:1417380. doi: 10.3389/fonc.2024.1417380. eCollection 2024.
6
Intravitreal aflibercept confounds interpretation of plasma VEGF (vascular endothelial growth factor) levels in POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome.玻璃体内注射阿柏西普干扰了POEMS（多发性神经病、器官肿大、内分泌病、单克隆丙种球蛋白病和皮肤改变）综合征中血浆血管内皮生长因子（VEGF）水平的解读。
EJHaem. 2024 Mar 30;5(2):421-422. doi: 10.1002/jha2.883. eCollection 2024 Apr.
7
Recent Advances in the Treatment and Supportive Care of POEMS Syndrome.POEMS综合征治疗与支持治疗的最新进展
J Clin Med. 2022 Nov 27;11(23):7011. doi: 10.3390/jcm11237011.
8
Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.达雷妥尤单抗联合来那度胺和地塞米松治疗伴有17p缺失的骨浆细胞瘤复发的POEMS综合征
Int J Hematol. 2023 Mar;117(3):463-467. doi: 10.1007/s12185-022-03459-w. Epub 2022 Oct 6.
9
Daratumumab-bortezomib-dexamethasone use in relapsed POEMS syndrome.达雷妥尤单抗-硼替佐米-地塞米松用于复发的POEMS综合征
EJHaem. 2022 Jun 5;3(3):1021-1024. doi: 10.1002/jha2.492. eCollection 2022 Aug.
10
Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report.采用达雷妥尤单抗、来那度胺和地塞米松联合治疗，随后进行自体造血干细胞移植治疗新诊断的多发性神经病、器官肿大、内分泌病、M 蛋白、皮肤改变综合征：一例报告。
J Med Case Rep. 2022 Aug 18;16(1):311. doi: 10.1186/s13256-022-03552-y.
本文引用的文献
1
Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma.达雷妥尤单抗联合来那度胺和地塞米松治疗初治多发性骨髓瘤。
N Engl J Med. 2019 May 30;380(22):2104-2115. doi: 10.1056/NEJMoa1817249.
2
Daratumumab plus lenalidomide and dexamethasone lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.达雷妥尤单抗联合来那度胺和地塞米松 vs. 来那度胺和地塞米松治疗复发或难治性多发性骨髓瘤：POLLUX 更新分析。
Haematologica. 2018 Dec;103(12):2088-2096. doi: 10.3324/haematol.2018.194282. Epub 2018 Sep 20.
3
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.欧洲骨髓瘤网络关于罕见浆细胞异常患者的诊断和管理的建议。
Leukemia. 2018 Sep;32(9):1883-1898. doi: 10.1038/s41375-018-0209-7. Epub 2018 Jul 23.
4
Daratumumab for POEMS Syndrome.达雷妥尤单抗治疗POEMS综合征
Mayo Clin Proc. 2018 Apr;93(4):542-544. doi: 10.1016/j.mayocp.2018.02.001.
5
POEMS syndrome: 2017 Update on diagnosis, risk stratification, and management.POEMS 综合征：2017 年关于诊断、风险分层和管理的更新。
Am J Hematol. 2017 Aug;92(8):814-829. doi: 10.1002/ajh.24802.
6
Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma.达雷妥尤单抗、来那度胺和地塞米松治疗多发性骨髓瘤。
N Engl J Med. 2016 Oct 6;375(14):1319-1331. doi: 10.1056/NEJMoa1607751.
7
Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis.来那度胺治疗POEMS综合征患者：一项系统评价与汇总分析
Leuk Lymphoma. 2014 Sep;55(9):2018-23. doi: 10.3109/10428194.2013.869329. Epub 2014 Feb 17.
8
Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.来那度胺治疗 POEMS 综合征的疗效：20 例患者的回顾性研究。
Am J Hematol. 2013 Mar;88(3):207-12. doi: 10.1002/ajh.23374. Epub 2013 Jan 18.
9
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.来那度胺联合地塞米松治疗自体外周血干细胞移植后复发的 POEMS 综合征的疗效。
Am J Hematol. 2012 Jun;87(6):641-2. doi: 10.1002/ajh.23195. Epub 2012 Apr 10.
10
Lenalidomide therapy in a patient with POEMS syndrome.来那度胺治疗POEMS综合征患者。
Blood. 2007 Aug 1;110(3):1075-6. doi: 10.1182/blood-2007-03-082354.
Zotero 插件